Jeffrey Kindler
Independent Director
Mr. Kindler is an experienced healthcare executive, investor and advisor. He brings over four decades of business experience and has held leadership positions at some of the world’s most recognized companies including Pfizer, where he served as Chairman & Chief Executive Officer, as well as McDonald’s Corporation and General Electric Company. Before that, he was a partner at the law firm of Williams & Connolly. He is currently CEO of Centrexion Therapeutics, a privately held biotechnology company, and a Senior Advisor to Blackstone. Mr. Kindler has a deep understanding of multinational corporate matters including regulations, litigations, compliance, crisis management, brand, franchise management, executive leadership and mergers & acquisitions.
Mr. Kindler is on the Boards of Precigen Inc., Jazz at Lincoln Center, Perrigo Pharmaceuticals, Terns Pharmaceuticals, Excision and Entity Risk, Inc. He is Chairman of the Talent & Compensation Committee of Perrigo Pharmaceuticals; Chairman of the Audit Committee and Member of Compensation Committee of Precigen Inc.; Chairman of the Compensation Committee of Terns Pharmaceuticals; and a member of the Audit and Compensation Committees of Jazz at Lincoln Center.
Mr. Kindler is based out of Miami, Florida, USA.
Education |
|
Age | 68 years |
Nationality | American |
Appointed | May 06, 2024 |
Tenure | 5 years |
Committee Membership | Member of the Risk Management Committee |